Aardvark Therapeutics, Inc. (AARD)

NASDAQ: AARD · Real-Time Price · USD

8.74

-1.40 (-13.81%)

At close: May 14, 2025, 4:00 PM

9.17

+0.43 (4.92%)

After-hours: May 14, 2025, 5:08 PM EDT

Aardvark Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May '25 May 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	190	-	-	-
Enterprise Value	117	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02
Quick Ratio	14.95	14.95	7.23	27.07
Current Ratio	15.05	15.05	7.50	27.72
Return on Equity (ROE)	-50.70%	-50.70%	-57.47%	-
Return on Assets (ROA)	-32.35%	-32.35%	-33.96%	-
Return on Capital (ROIC)	-34.67%	-34.67%	-36.34%	-
Buyback Yield / Dilution	-0.90%	-0.90%	-1.78%	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q